CAS 149647-78-9
:Vorinostat
- Ccris 8456
- M344
- N-Hydroxy-N'-phenyloctanediamide
- N-Hyrdroxy-N'-phenyloctanediamide
- N<sup>1</sup>-Hydroxy-N<sup>8</sup>-phenyloctanediamide
- Octanediamide, N-hydroxy-N'-phenyl-
- Octanediamide, N<sup>1</sup>-hydroxy-N<sup>8</sup>-phenyl-
- SAHA cpd
- Suberanilohydroxamic acid
- Suberoyl anilide bishydroxamide
- Suberoylanilide Hydroxamic Acid
- Unii-58Ifb293Ji
- Vorinostat [USAN]
- Wt 171
- Zolinza
- Octanediamide, N1-hydroxy-N8-phenyl-
- SAHA
- Vedi altri sinonimi
N-Hydroxy-N'-phenyloctanediamide
CAS:Formula:C14H20N2O3Purezza:>98.0%(HPLC)(N)Colore e forma:White to Light yellow to Light orange powder to crystalPeso molecolare:264.33N-Hydroxy-N'-phenyloctanediamide
CAS:Formula:C14H20N2O3Purezza:98%Colore e forma:SolidPeso molecolare:264.3202Vorinostat
CAS:Vorinostat (SAHA) is a pan-histone deacetylase (HDAC) inhibitor (IC50=10 nM) with inhibitory activity against HDAC1/2/3/6/7/11.Formula:C14H20N2O3Purezza:99.47% - 99.65%Colore e forma:White Crystalline SolidPeso molecolare:264.32N-Hydroxy-N'-Phenyloctanediamide
CAS:N-Hydroxy-N'-PhenyloctanediamidePurezza:99%Peso molecolare:264.32g/molRef: 4Z-V-072
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaRef: 4Z-V-071
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaVorinostat
CAS:Prodotto controllatoFormula:C14H20N2O3Colore e forma:White SolidPeso molecolare:264.32Ref: 4Z-V-079
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaVorinostat
CAS:Formula:C14H20N2O3Purezza:≥ 98.0%Colore e forma:White to off-white powderPeso molecolare:264.32Suberoylanilide Hydroxamic Acid
CAS:Prodotto controllatoFormula:C14H20N2O3Colore e forma:White SolidPeso molecolare:264.32Vorinostat - Bio-X ™
CAS:Vorinostat is a histone deacetylase inhibitor which interferes with gene transcription regulatory mechanisms. It is used to treat cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma (CTCL) following prior systemic therapies. This drug inhibits the enzymatic activity of histone deacetylases HDAC1, HDAC2 and HDAC3 (Class I) and HDAC6 (Class II).
Formula:C14H20N2O3Purezza:Min. 99 Area-%Colore e forma:PowderPeso molecolare:264.32 g/molVorinostat
CAS:Vorinostat is a histone deacetylase inhibitor which interferes with gene transcription regulatory mechanisms. It targets histones and non-histone proteins within transcription factor complexes involved in regulation of cell proliferation (p53), protein stability (Hsp90), apoptosis (Bcl-2 family), cell motility (α-tublin), and angiogenesis (HIF-1α). Vorinostat affects epigenetic regulation in various cancers and has been used in clinical trials as anticancer drug.
Formula:C14H20N2O3Purezza:Min. 98 Area-%Colore e forma:White PowderPeso molecolare:264.32 g/molVorinostat
CAS:M06303 - Vorinostat
Formula:C14H20N2O3Purezza:97%Colore e forma:SolidPeso molecolare:264.325Suberoylanilide Hydroxamic Acid-13C6
CAS:Prodotto controllatoApplications is the labeled form of Suberoylanilide Hydroxamic Acid (S688700), which is a potent, selective, cell permeable histone deacetylase inhibitor (HDAC), displays anti-angiogenic activity by interfering with VEGF signaling in human umbilical vein endothelial cells (HUVECs) and induces differentiation in human breast cancer cells. Also it is a potent histone deacetylase inhibitor.
References Richon, V.M., et al.: Proc. Natl. Acad.Sci. USA, 95, 3003 (1988), Munster, P.N., et al.: Cancer Res., 61, 8492 (2001), Deroanne, C.F., et al.: Oncogene, 21, 247 (2002)Formula:C6C8H20N2O3Colore e forma:NeatPeso molecolare:270.276










